|
ACSL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99029681624552E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.7142953723237E-12 |
| Normal-vs-Stage2 |
2.53870036104331E-10 |
| Normal-vs-Stage3 |
2.39710029603657E-10 |
| Normal-vs-Stage4 |
4.302600E-03 |
| Stage1-vs-Stage2 |
7.000000E-01 |
| Stage1-vs-Stage3 |
9.011600E-01 |
| Stage1-vs-Stage4 |
8.557600E-01 |
| Stage2-vs-Stage3 |
5.925200E-01 |
| Stage2-vs-Stage4 |
7.190600E-01 |
| Stage3-vs-Stage4 |
9.330200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66533453693773E-12 |
| Normal-vs-AfricanAmerican |
1.58120000426365E-08 |
| Normal-vs-Asian |
2.308400E-01 |
| Caucasian-vs-AfricanAmerican |
2.303200E-01 |
| Caucasian-vs-Asian |
8.433900E-02 |
| AfricanAmerican-vs-Asian |
3.388000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.23209999999918E-05 |
| Male-vs-Female |
5.303800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.53990162235596E-11 |
| Normal-vs-Extreme_Weight |
1.62492241884138E-12 |
| Normal-vs-Obese |
8.79869510583831E-11 |
| Normal-vs-Extreme_Obese |
1.482700E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.820200E-01 |
| Normal_Weight-vs-Obese |
3.400800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.269200E-01 |
| Extreme_Weight-vs-Obese |
2.298000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.009200E-01 |
| Obese-vs-Extreme_Obese |
6.552600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.023940E-03 |
| Normal-vs-Age(41-60Yrs) |
2.11299866492709E-11 |
| Normal-vs-Age(61-80Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(81-100Yrs) |
1.704540E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.373000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.616700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.204000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.142100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.238200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.899800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.14273043752655E-14 |
| Normal-VS-Type2 PRCC |
2.47468712188947E-13 |
| Normal-VS-KIRP CIMP |
4.965900E-02 |
| Normal-VS-Unclassified PRCC |
1.078260E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.596200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.203700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.834370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.381100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.716840E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.666400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.66280331118196E-11 |
| Normal-vs-N1 |
1.297870E-03 |
| Normal-vs-N2 |
4.379600E-02 |
| N0-vs-N1 |
7.796200E-02 |
| N0-vs-N2 |
2.376800E-01 |
| N1-vs-N2 |
7.952400E-01 |
|
|
